Literature DB >> 15053501

Effect of activation regimens for rat oocytes on full-term development after round spermatid injection.

Megumi Kato1, Ayako Ishikawa, Shinichi Hochi, Masumi Hirabayashi.   

Abstract

The present study was designed to compare the effect of two activation regimens for rat oocytes on full-term development after round spermatid injection (ROSI). Oocytes were treated either with 1.25 mM SrCl2 for 20 min or with two direct-current (DC) pulses at 100 V/mm for 99 msec followed by exposure to 2 mM 6-dimethylaminopurine (6-DMAP) for 20 min. Single spermatids then were injected into the oocytes that were ready for polar body extrusion. The proportions of oocytes surviving injection and exhibiting pronuclear formation were comparable between the SrCl2 group (76.8% and 45.6%, respectively) and the DC+6-DMAP group (78.3% and 34.9%, respectively). More SrCl2-activated ROSI oocytes (44.2%) cleaved into the two-cell stage than did those activated with DC+6-DMAP (34.7%). However, the proportions of the two-cell embryos developing to morulae/blastocysts and live offspring were significantly (P = 0.0005 and 0.042) lower in the SrCl2 group (12.3 and 6.1%, respectively) than the DC+6-DMAP group (36.1 and 14.6%, respectively). Our results indicate DC+6-DMAP is better than SrCl2 for oocyte activation prior to successful ROSI of rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053501

Source DB:  PubMed          Journal:  Contemp Top Lab Anim Sci        ISSN: 1060-0558


  2 in total

1.  Self renewal, expansion, and transfection of rat spermatogonial stem cells in culture.

Authors:  F Kent Hamra; Karen M Chapman; Derek M Nguyen; Ashley A Williams-Stephens; Robert E Hammer; David L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

Review 2.  The present status of artificial oocyte activation in assisted reproductive technology.

Authors:  Kaoru Yanagida; Yoko Fujikura; Haruo Katayose
Journal:  Reprod Med Biol       Date:  2008-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.